Metacognition Assessment in Patient With Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Registration Number
- NCT04240379
- Lead Sponsor
- University Hospital, Grenoble
- Brief Summary
This study will assessed the level of consciousness of MS patients suffering of cognitive and motor disorders. Understanding the awareness of the disease is crucial to allow better management of these patients. It has been shown, for other neurological pathologies, that a lack of awareness of deficits leads to inefficient rehabilitation and a disorder of understanding the impact of deficits in daily activities. Metacognition could be altered with age, so we will include participants between 18 and 60 years old.
- Detailed Description
Subject who have to do neurological assessement by the Multiple sclerosis Functional Composite (MSFC) will be enrolled.
The patient will estimate the time to undergo the test. This time will be compared to the time really make by the patient to realise test.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- Diagnosis of multiple sclerosis
- Voluntary for participate to study
- Neurological disease other than Multiple Sclerosis
- psychiatric disease, other than depressiveness
- illicit substance abuse
- Persons referred to in Articles L1121-5 to 8 of the French Public Health Code
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Metacognitive precision Day 1 Metacognitive precision based on Multiple Sclerosis Functional Composite (MSFC) score
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chu Grenoble Alpes
🇫🇷Grenoble, France